Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now

DENTSPLY SIRONA (XRAY) is well-poised for growth on a robust product portfolio and continued focus on research and development. However, forex remains a concern. Shares of this Zacks Rank #3 (Hold) company have lost 24% year to date against the industry's 0.3% growth. The S&P 500 Index has gained 20.5% in the same time frame. XRAY, with a market capitalization of $5.41 billion, is a global leader in the design, development, manufacturing and marketing of dental consumables, dental laboratory products, denta ...